The use of recombinant FVIIa in a patient with glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 3, 2009, Pages 215-217

  Erduran, Erol ^a   Aksoy, Ayşe ^b,c   Zaman, Dilek ^c  

^a Pediatric Hematology Division   (Turkey)

^b Pediatric Neurology Division   (Turkey)

^c KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Glanzmann thrombasthenia; recombinant FVIIa; tonsillectomy

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RFVIIA; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD CLOTTING TEST; BLOOD DISEASE; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; ERYTHROCYTE CONCENTRATE; GLANZMANN DISEASE; HEMOSTASIS; HUMAN; HYPERFIBRINOLYSIS; HYPERTROPHIC TONSIL; HYPERTROPHY; LABORATORY TEST; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RECURRENT DISEASE; REPEATED DRUG DOSE; SURGICAL TECHNIQUE; THROMBOCYTE TRANSFUSION; TONSILLECTOMY; TONSILLITIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; BLOOD LOSS, SURGICAL; FACTOR VIIA; HUMANS; MALE; RECOMBINANT PROTEINS; THROMBASTHENIA; TONSILLECTOMY;

EID: 67650888606     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32831d0f69     Document Type: Article

References (15)

1. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990; 75:1383-1395.
2. Tengborn L, Petruson B. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thromb Haemost 1996; 75:981-982.
3. Vrielink H, Reesink HW. Transfusion-transmissible infections. Curr Opin Hematol 1998; 5:396-405.
4. BayA,Öner AF, Ç ankaya H,DoǧanM.The use of recombinant factor VIIa in a child with Glanzmann thrombasthenia. Int J Hematol Oncol 2006; 16:87-89.
5. Roberts HR. Recombinant factor VIIa: a general hemostatic agent? Yes. J Thromb Haemost 2004; 2:691-694.
6. Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineu DA. Prospective, randomized trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 1998; 80:773-778.
7. Weiskopf RB. Recombinant-activated coagulation factor VIIa (NovoSeven®): current development. Vox Sanguinis 2007; 92:281-288.
8. Collet J, Park D, Lesty C, Soria J, Montalescot G, Weisel J. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 2000; 20:1354-1361.
9. Key NS, Aledort LM, Beardsley D, Cooper HA, Davignon G, Ewenstein BM, et al. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost 1998; 80:912-918.
10. Poon M-C, Demers C, Jobin F, Wu JW. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 1999; 94:3951-3953.
11. Almeida AM, Khair K, Hann I, Liesner R. The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol 2003; 121:477-481.
12. Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high dose factor VIIa is independent of tissue factor. Br J Haematol 1997; 99:542-547.
13. Hoffman M, Monroe DM III, Roberts HR. Activated factor VII activates factor IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 1998; 9:561-565.
14. Martinowitz U, Michaelson M, the Israeli Multidisciplinary rFVIIa Task Force. Guidelines for the use of recombinant factor VIIa (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.
15. Poon M-C, d'Oiron R, von Depka M, Khair K, Negrier C, Karafoulidou A, et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. J Thromb Haemost 2004; 2:1096-1103.